Home NDC 67457-857 Adenosine
Product NDC 67457-857
11-digit product format 674570857
Labeler code 67457
Product ID 67457-857_15f8979f-4d90-48c6-bf65-3d1a4064536b
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name adenosine
Dosage form INJECTION, SOLUTION
Route INTRAVENOUS
Labeler Mylan Institutional LLC
Application ANDA090212
Marketing category ANDA
Marketing start 2014-03-28
Substance ADENOSINE
Active strength 3 mg/mL
Pharmacologic classes Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A090212-001 ADENOSINE ADENOSINE 60MG/20ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2014-03-28 A090212-002 ADENOSINE ADENOSINE 90MG/30ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2014-03-28
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 82 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A090212-001 ADENOSINE 60MG/20ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2014-03-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A090212-002 ADENOSINE 90MG/30ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2014-03-28 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A090212-001 ADENOSINE 60MG/20ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2014-03-28 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A090212-002 ADENOSINE 90MG/30ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2014-03-28 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A090212-001 ADENOSINE 60MG/20ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2014-03-28 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A090212-002 ADENOSINE 90MG/30ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2014-03-28 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A090212-001 ADENOSINE 60MG/20ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2014-03-28 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A090212-002 ADENOSINE 90MG/30ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2014-03-28 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A090212-001 ADENOSINE 60MG/20ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2014-03-28 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A090212-002 ADENOSINE 90MG/30ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2014-03-28 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A090212-001 ADENOSINE 60MG/20ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2014-03-28 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A090212-002 ADENOSINE 90MG/30ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2014-03-28 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A090212-001 ADENOSINE 60MG/20ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2014-03-28 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A090212-002 ADENOSINE 90MG/30ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2014-03-28 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A090212-001 ADENOSINE 60MG/20ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2014-03-28 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A090212-002 ADENOSINE 90MG/30ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2014-03-28 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A090212-001 ADENOSINE 60MG/20ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2014-03-28 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A090212-002 ADENOSINE 90MG/30ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2014-03-28 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A090212-001 ADENOSINE 60MG/20ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2014-03-28 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A090212-002 ADENOSINE 90MG/30ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2014-03-28 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A090212-001 ADENOSINE 60MG/20ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2014-03-28 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A090212-002 ADENOSINE 90MG/30ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2014-03-28 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A090212-001 ADENOSINE 60MG/20ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2014-03-28 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A090212-002 ADENOSINE 90MG/30ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2014-03-28 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A090212-001 ADENOSINE 60MG/20ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2014-03-28 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A090212-002 ADENOSINE 90MG/30ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2014-03-28 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A090212-001 ADENOSINE 60MG/20ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2014-03-28 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 A090212-002 ADENOSINE 90MG/30ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2014-03-28 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A090212-001 ADENOSINE 60MG/20ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2014-03-28 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A090212-002 ADENOSINE 90MG/30ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2014-03-28 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A090212-001 ADENOSINE 60MG/20ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2014-03-28 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 A090212-002 ADENOSINE 90MG/30ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2014-03-28 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A090212-001 ADENOSINE 60MG/20ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2014-03-28 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 A090212-002 ADENOSINE 90MG/30ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2014-03-28 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A090212-001 ADENOSINE 60MG/20ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2014-03-28 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 A090212-002 ADENOSINE 90MG/30ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2014-03-28 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A090212-001 ADENOSINE 60MG/20ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2014-03-28 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 A090212-002 ADENOSINE 90MG/30ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2014-03-28 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A090212-001 ADENOSINE 60MG/20ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2014-03-28 782e0a99824c…2021-12-28 21:50 UTC 2021-12 A090212-002 ADENOSINE 90MG/30ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2014-03-28 782e0a99824c…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 3 · 82 observed states.
Additional Listing Data#
Finished product Yes
Brand name base Adenosine
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength ADENOSINE 3 mg/mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination K72T3FS567 Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1654035 Internal RxNorm lookup 1654040 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 67457-857-30 Adenosine 1 in 1 CARTON INJECTION, SOLUTION 1 2 67457-857-30 Adenosine 30 mL in 1 VIAL INJECTION, SOLUTION 30 2
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 67457-857 ADENOSINE INJECTION, SOLUTION [MYLAN INSTITUTIONAL LLC] 2 Current NDC, Legacy NDC, 2 package rows 20230120_23e5c868-944f-4cc8-887f-9a2dc811af92.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 67457-857-30 67457085730 1 VIAL in 1 CARTON (67457-857-30) / 30 mL in 1 VIAL 1 vial 2017-08-31 0000-00-00 No No Current